Related Experiment Videos
Summary
Slow intravenous infusion of amphotericin B (amB) caused fever in rabbits, with higher doses leading to more sustained fevers. Endotoxin-tolerant rabbits showed reduced fever responses to amB, while mice did not develop fever.
Area of Science:
- Pharmacology
- Toxicology
- Immunology
Background:
- Amphotericin B (amB) is a critical antifungal agent.
- Fever is a common side effect of intravenous drug administration.
- Understanding pyrogenic responses to amB is crucial for patient safety.
Purpose of the Study:
- To investigate the pyrogenic effects of amphotericin B (amB) in rabbits.
- To compare fever induction by slow infusion versus bolus injection of amB.
- To determine the threshold pyrogenic dose of amB in rabbits.
Main Methods:
- Intravenous administration of amphotericin B (amB) to male adult rabbits via slow infusion and bolus injection.
- Dose-ranging studies to identify pyrogenic thresholds.
- Assessment of rectal temperature changes.
- Evaluation of amB pyrogenicity in endotoxin-tolerant rabbits and mice.
Main Results:
- Slow intravenous infusion of amB induced a moderate, dose-dependent fever in rabbits.
- Bolus injection of amB was less pyrogenic, requiring higher doses for fever induction.
- The threshold pyrogenic dose of amB was approximately 0.16 mg/kg.
- Endotoxin-tolerant rabbits exhibited a blunted febrile response to amB.
- No fever was observed in mice treated with amB.
Conclusions:
- The route and rate of amphotericin B administration significantly influence its pyrogenic potential in rabbits.
- Fever response to amB is dose-dependent and can be modulated by endotoxin tolerance.
- Amphotericin B does not appear to be pyrogenic in mice.